Notes

SP1 activated-lncRNA SNHG1 mediates the creation of epilepsy through miR-154-5p/TLR5 axis.
Malaria is caused by different species of Plasmodium; among which P. falciparum is the most severe. Coptis teeta is an ethnomedicinal plant of enormous importance for tribes of northeast India.

In this study, the antimalarial activity of the methanol extracts of Coptis teeta was evaluated in vitro and lead identification was carried out via in silico study.

On the basis of the in vitro results, in silico analysis by application of different modules of Discovery Studio 2018 was performed on multiple targets of P. falciparum taking into consideration some of the compounds reported from C. teeta.

The IC50 of the methanol extract of Coptis teeta was reported to be 0.08 μg/ml in 3D7 strain and 0.7 μg/ml in Dd2 strain of P. falciparum. From the docking study, noroxyhydrastatine was observed to have better binding affinity in comparison to chloroquine. The binding of noroxyhydrastinine with dihydroorotate dehydrogenase was further validated by molecular dynamics simulation and was observed to be significantly stable in comparison to the co-crystal inhibitor. During simulations, it was observed that noroxyhydrastinine retained the interactions, giving strong indications of its effectiveness against the P. falciparum proteins and stability in the binding pocket. From the Density-functional theory analysis, the bandgap energy of noroxyhydrastinine was found to be 0.186 Ha, indicating a favorable interaction.

The in silico analysis as an addition to the in vitro results provides strong evidence of noroxyhydrastinine as an antimalarial agent.
The in silico analysis as an addition to the in vitro results provides strong evidence of noroxyhydrastinine as an antimalarial agent.
Due to the importance of fused chromene motifs in bioactive compounds, the current research aimed to explore novel methods for the construction of heterocyclic scaffolds. Regarding the attractive features of developing novel methodological approaches in the presence of heterogeneous nanocatalysts, we will try to synthesize 4-aryl-3,4-dihydro-2H,5H-pyrano[3,2- c]chromene-2,5-diones and 8-aryl-7,8-dihydro-6H-[1,3]dioxolo[4,5-g]chromene-6-ones.

The aim of the present research was to prove the catalytic efficiency of the synthesized nickel(II) chromite nanoparticles (NiCr2O4 NPs) as bifunctional Lewis acid-Lewis base catalyst in the synthesis of pyrano[c]chromenediones and [1,3]dioxolo[g]chromeneones.

Pyrano[c]chromenediones and [1,3]dioxolo[g]chromeneones were conveniently prepared from a three-component condensation reaction between aromatic aldehydes, Meldrum's acid, and active methylene compounds including 4-hydroxycoumarin or 3,4-methylenedioxyphenol using NiCr2O4 NPs as an efficient, readily availablerimental procedures, higher yields, shorter reaction times, and the use of easily obtained and recyclable catalyst compared with previously reported methods and has a great scope for development.
In the late 20th century, the leading role of signaling pathways in various cancers is revealed via some genome's systematic investigations. The Akt/GSK-3 signaling pathway is one of the critical signaling pathways dysregulated in numerous human cancers. The Akt cascade acts in the cancer process by regulating apoptosis, cell cycle, metabolism, and cells' longevity. The GSK-3 is downstream of Akt, which has an opposite role in cancer progression.

Attending to the importance of the Akt/GSK-3 pathway in cancer progression and the positive result of natural products in cancer treatment, this research is designed to review effective herbal medicines in one of the involvement critical signal pathways of cancer for developing novel anticancer drugs.

Keywords "plant", "natural", "cancer", "AKT", and "GSK" were searched through the "Scopus" and "Google scholar" databases up to 30th August 2020. Papers linking to pharmacology, toxicology, and pharmaceutics were collected and discussed.

The Akt/GSK-3 signaling hibitory effects, and (3) anti-metastatic and angiogenesis effects. As the tendency to use natural products increases, we gathered 64 plants or bioactive components with the anticancer activity via the Akt/GSK-3 signaling pathway. Since most of these investigations have been conducted on cell lines, these plants can be the right candidate to be evaluated in human trials.CA125 is a well-known tumor marker for diagnosis, monitoring, and risk stratification in ovarian cancer. It is not specific for malignant tumors and may be elevated in benign disease. In the past two decades, increasing evidence has emerged suggesting that the plasma level of CA125 can serve as a novel surrogate of heart failure (HF). CA125 in patients with HF is synthesized by serous epithelial cells in response to both mechanical and inflammatory stimuli. In patients with HF, regardless of etiology, CA125 levels correlate with the severity of clinical, hemodynamic, and echocardiographic parameters and with other biomarkers. Elevated CA125 can identify patients at high risk of rehospitalization and mortality, whether short- or long-term. Serial measurements and combination with different pathophysiology biomarkers can provide a more accurate prognosis value. It also can guide treatment as a robust biomarker of fluid overload and inflammation, particularly for diuretic dose optimization. These properties make it a very promising candidate for risk stratification and treatment guidance of HF.Cardiovascular disease (CVD) is one of the leading causes of death worldwide. Chronic atherosclerosis induced vascular inflammation and perturbation of lipid metabolism is believed to be a major cause of CVD. Interplay of innate and adaptive Immune system has been interwined with various risk factors associated with the initiation and progression of atherosclerosis in CVD. A large body of evidence indicates a correlation between immunity and atherosclerosis. Retention of plasma lipoproteins in arterial subendothelial wall triggers the T helper type 1 (Th1) cells and monocyte-derived macrophages to form atherosclerotic plaques. In the present review, we will discuss the pathogenesis of CVD in relation to atherosclerosis with a particular focus on pro-atherogenic role of immune cells. Recent findings have also suggested anti-atherogenic roles of different B cell subsets. Therapeutic approaches to target atherosclerosis risk factors have reduced the mortality, but a need exists for the novel therapies to treat arterial vascular inflammation. These insights into the immune pathogenesis of atherosclerosis can lead to new targeted therapeutics to abate cardiovascular mortality and morbidity.
Methotrexate (MTX) is the representative drug among the disease- modifying anti-rheumatic drugs. However, the conventional treatment with MTX showed many limitations and side effects.

To strengthen the targeting ability and circulation time of MTX in the treatment of rheumatoid arthritis, the present study focused on developing a novel drug delivery system of methotrexate-loaded human serum albumin nanoparticles (MTX-NPs) modified by mannose, which are referred to as MTX-M-NPs.

Firstly, mannose-derived carboxylic acid was synthesized and further modified on the surface of MTX-NPs to prepare MTX-M-NPs. The formulation of nanoparticles was optimized by the method of central composite design (CCD), with the drug lipid ratio, oil-aqueous ratio, and cholesterol or lecithin weight as the independent variables. The average particle size and encapsulation efficiency were the response variables. The response of different formulations was calculated, and the response surface diagram, contour diagram, and mathematn for the treatment of RA.Mitochondrial dysfunction and oxidative stress are prominent features of a plethora of human disorders. Dysregulation of mitochondrial functions represents a common pathogenic mechanism of diseases such as neurodegenerative disorders and cancer. The maintenance of the Nicotinamide adenine dinucleotide (NAD+) pool, and a positive NAD+/NADH ratio, are essential for mitochondrial and cell functions. The synthesis and degradation of NAD+ and transport of its key intermediates among cell compartments play an important role in maintaining optimal NAD levels, for the regulation of NAD+-utilizing enzymes, such as sirtuins (Sirt), poly-ADP-ribose polymerases, and CD38/157 enzymes, either intracellularly as well as extracellularly. In this review, we present and discuss the links between NAD+, NAD+-consuming enzymes, mitochondria functions, and diseases. Attempts to treat various diseases with supplementation of NAD+ cycling intermediates and inhibitors of sirtuins and ADP-ribosyl transferases may highlight a possible therapeutic approach for therapy of cancer and neurodegenerative diseases.
Osteonecrosis of Femoral Head (ONFH) is a common complication in orthopaedics, wherein femoral structures are usually damaged due to the impairment or interruption of femoral head blood supply.

In this study, an automatic approach for the classification of the early ONFH with deep learning has been proposed.

All femoral CT slices according to their spatial locations with the Convolutional Neural Network (CNN) are first classified. Therefore, all CT slices are divided into upper, middle or lower segments of femur head. Then the femur head areas can be segmented with the Conditional Generative Adversarial Network (CGAN) for each part. The Convolutional Autoencoder is employed to reduce dimensions and extract features of femur head, and finally K-means clustering is used for an unsupervised classification of the early ONFH.

To invalidate the effectiveness of the proposed approach, the experiments on the dataset with 120 patients are carried out. The experimental results show that the segmentation accuracy is higher than 95%. The Convolutional Autoencoder can reduce the dimension of data, the Peak Signal- to-Noise Ratios (PSNRs) are better than 34dB for inputs and outputs. Meanwhile, there is a great intra-category similarity, and a significant inter-category difference.

The research on the classification of the early ONFH has a valuable clinical merit, and hopefully it can assist physicians to apply more individualized treatment for patient.
The research on the classification of the early ONFH has a valuable clinical merit, and hopefully it can assist physicians to apply more individualized treatment for patient.
This study aims to investigate the existence of any Diffusion Tensor Imaging (DTI) value differences in Brain Metastases (BM) due to lung adenocarcinoma based on the Epidermal Growth Factor Receptor (EGFR) gene mutation status.

17 patients with 32 solid intracranial metastatic lesions from lung adenocarcinoma were included prospectively. Patients were divided according to the EGFR mutation status as EGFR (+) (group 1, n8) and EGFR wild type (group 2, n9). The Fractional Anisotropy (FA), apparent diffusion coefficient (ADC), normalized ADC (nADC), Axial Diffusivity (AD), and Radial Diffusivity (RD) values were measured from the solid component of the metastatic lesions and nADC values were calculated. DTI values were compared between group 1 and group 2. The receiver-operating characteristic analysis was used to obtain cut-off values for the parameters presenting a statistical difference between the EGFR gene mutation-positive and wild type group.

There were statistically significant differences in measured ADC, nADC, AD, and RD values between group 1 and group 2.
Here's my website: